Showing results (201-210 of 406) with videos related to
Sort By:
Pageof 41
BMC Medical Genomics|July 13, 2011
Identification of transcriptional regulatory networks specific to pilocytic astrocytomaHrishikesh Deshmukh, Jinsheng Yu, Jahangheer Shaik, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2019
The Misclassification of Diffuse Gliomas: Rates and OutcomesJ Bryan Iorgulescu, Matthew Torre, Maya Harary, et al.Radiation Oncology (London, England)|June 1, 2010
Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningiomaA Gabriella Wernicke, Adam P Dicker, Michal Whiton, et al.Journal of Neuro-Oncology|September 24, 2013
The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular featuresMatthew D Cykowski, Richard A Allen, Angela C Kanaly, et al.Neuro-Oncology|August 29, 2024
Meningeal solitary fibrous tumor cell states phenocopy cerebral vascular development and homeostasisKanish Mirchia, Abrar Choudhury, Tara Joseph, et al.Journal of Neurosurgery|December 15, 2010
Impact of bevacizumab chemotherapy on craniotomy wound healingAaron J Clark, Nicholas A Butowski, Susan M Chang, et al.Neuro-Oncology|March 5, 2010
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)Fabio M Iwamoto, Kathleen R Lamborn, H Ian Robins, et al.Brain Pathology (Zurich, Switzerland)|September 30, 2017
Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entitiesMatthew D Wood, Tarik Tihan, Arie Perry, et al.Neuro-Oncology|May 11, 2012
Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangementGabriel A Bien-Willner, Dolores López-Terrada, Meena B Bhattacharjee, et al.Journal of Pediatric Hematology/Oncology|October 23, 2020
Adjuvant Maintenance Larotrectinib Therapy in 2 Children With NTRK Fusion-positive High-grade CancersMaria Carter-Febres, Netta Schneller, Douglas Fair, et al.Pageof 41